Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
Open accessThe DOI matches its Crossref record; 148 of the 150 references it cites were found in a registry or an index.
Abstract
Cancer stem cells are a subset of cells within the tumor that possess the ability to self-renew as well as differentiate into different cancer cell lineages. The exact mechanisms by which cancer stem cells arise is still not completely understood. However, current research suggests that cancer stem cells may originate from normal stem cells that have undergone genetic mutations or epigenetic changes. A more recent discovery is the dedifferentiation of cancer cells to stem-like cells. These stem-like cells have been found to express and even upregulate induced pluripotent stem cell markers known as Yamanaka factors. Here we discuss developments in how cancer stem cells arise and consider how environmental factors, such as hypoxia, plays a key role in promoting the progression of cancer stem cells and metastasis. Understanding the mechanisms that give rise to these cells could have important implications for the development of new strategies in cancer treatments and therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, hypoxia promotes self-renewal by activation of Wnt and Notch signaling pathways and embryonic stem cell transcription factors, and it modulates differentiation of tumor cells and tumor-associated stromal cells [86,87,88].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [87]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 1×
“Several markers have been reported to be expressed in CSCs including the Yamanaka transcription factors OCT4, NANOG, SOX2, KLF4, and c-MYC (62, 63).”
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“This was followed by the discovery of CSCs within a solid breast tumor environment (16).”
BackgroundBonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864 · cited 4×
“Two landmark studies involving immune-deficient mice models showed that leukemic cells expressing the same markers seen in adult human hematopoietic stem cells (CD34+CD38−) initiated hematopoietic malignancy (15, 38).”
BackgroundInfluentialCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162 · cited 1×
“Historically, cancer progression has been firmly established in mutational processes and clonal expansion (107).”
BackgroundEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067 · cited 1×
“However, recent studies have implicated CSCs in the resistance (108) and recurrence of tumors (109).”
BackgroundEpithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Cited by
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J.-M., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 188
“110 This dynamic equilibrium between CSCs and non-CSCs makes it dif fi cult to eradicate CSCs by targeting speci fi c markers, as non-CSCs can also repopulate tumors.”
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer.
Ronca, R., & Supuran, C. (2024) · Biochimica et biophysica acta. Reviews on cancer · doi:10.1016/j.bbcan.2024.189120 · Cited by 106
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
Verona, F., Bella, S. D., Schirano, R., Manfredi, C., Angeloro, F., Bozzari, G., Todaro, M., Giannini, G., Stassi, G., & Veschi, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529847 · Cited by 56
Kunachowicz, D., Tomecka, P., Sędzik, M., Kalinin, J., Kuźnicki, J., & Rembiałkowska, N. (2025) · Cells · doi:10.3390/cells14141057 · Cited by 54
“HIF-1 α is a powerful glycolysis-inducing factor through binding to hypoxia-responsive elements, which are present in the promoters of genes encoding key glycolytic enzymes and transporters, such as glucose transporters, hex-okinase 2, lactate dehydrogenase A, and monocarboxylate transporters [44].”
Metadata
- Authors
- Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y.
- Affiliations
- Western Michigan University (US)
- Corresponding author
- Li, Yong
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2023-08-08
- Volume
- 13
- Pages
- 1227884-1227884
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC10442830
- OpenAlex
- W4385658940
- Cited by
- 41
- References
- 150
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 10 · 2023: 1
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Western Michigan University
- Stryker
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- cancer stem cells, hypoxia, tumor reprogramming, dedifferentiation, Yamanaka factors, self-renewal, metastasis, tumor progression, normal stem cells, epigenetic modifications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. https://app.cochat.ai/papers/10.3389/fonc.2023.1227884
- The paper
- Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y. (2023). Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1227884
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.